Literature DB >> 21284651

Decline of antibodies in XLA infant: when to start IVIG.

I U Okocha1, C G Hanson, J Chinen, W T Shearer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21284651      PMCID: PMC3408709          DOI: 10.1111/j.1398-9995.2010.02481.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  5 in total

Review 1.  Clinical consequences of defects in B-cell development.

Authors:  Andre M Vale; Harry W Schroeder
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

2.  Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation.

Authors:  F M Munoz; J A Englund; C C Cheesman; M L Maccato; P M Pinell; M H Nahm; E O Mason; C A Kozinetz; R A Thompson; W P Glezen
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

3.  Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants.

Authors:  Jolice P van den Berg; Elisabeth A M Westerbeek; Guy A M Berbers; Pieter G M van Gageldonk; Fiona R M van der Klis; Ruurd M van Elburg
Journal:  Pediatr Infect Dis J       Date:  2010-09       Impact factor: 2.129

Review 4.  Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

Authors:  Jordan S Orange; Elham M Hossny; Catherine R Weiler; Mark Ballow; Melvin Berger; Francisco A Bonilla; Rebecca Buckley; Javier Chinen; Yehia El-Gamal; Bruce D Mazer; Robert P Nelson; Dhavalkumar D Patel; Elizabeth Secord; Ricardo U Sorensen; Richard L Wasserman; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

Review 5.  Primary B cell immunodeficiencies: comparisons and contrasts.

Authors:  Mary Ellen Conley; A Kerry Dobbs; Dana M Farmer; Sebnem Kilic; Kenneth Paris; Sofia Grigoriadou; Elaine Coustan-Smith; Vanessa Howard; Dario Campana
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

  5 in total
  3 in total

Review 1.  An update on the use of immunoglobulin for the treatment of immunodeficiency disorders.

Authors:  Stephanie Albin; Charlotte Cunningham-Rundles
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

2.  Advances in neonatal screening for primary immune deficiencies.

Authors:  Tingting Jiang; Zhenguang Li; Qiuli Zhang
Journal:  Exp Ther Med       Date:  2016-03-01       Impact factor: 2.447

3.  Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia.

Authors:  Keisuke Sugimoto; Hitomi Nishi; Tomoki Miyazawa; Norihisa Wada; Akane Izu; Takuji Enya; Mitsuru Okada; Tsukasa Takemura
Journal:  BMC Nephrol       Date:  2014-07-08       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.